サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1510222

BNP・NT-proBNPの世界市場規模：用途別、検査場所別、地域別予測（2022年～2032年）

Global BNP And NTproBNP Market Size study, by Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Others), by Location of Testing (Point of Care Testing, Laboratory Testing) and Regional Forecasts 2022-2032

出版日
ページ情報
英文 200 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
BNP・NT-proBNPの世界市場規模：用途別、検査場所別、地域別予測（2022年～2032年）
出版日: 2024年07月06日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のBNP・NT-proBNPの市場規模は、2023年に約12億5,320万米ドルに達し、予測期間2024年～2032年に12.20％超の健全な成長率で成長すると予測されています。 BNP（B型ナトリウム利尿ペプチド）とNT-proBNP（BNPのN末端プロホルモン）は、心不全の診断に用いられるバイオマーカーです。

BNPは心臓の心室で圧力と体積の過負荷に反応して産生されるホルモンです。NT-proBNP（N末端プロb型ナトリウム利尿ペプチド）はBNP（B型ナトリウム利尿ペプチド）の前駆体であり、両者とも心室の容積拡大と圧負荷に応答して心臓から放出されます。NT-proBNPはBNPと同じ前駆体分子から切断され、その安定性と循環半減期の長さから、心不全の診断と管理のためのバイオマーカーとして用いられています。BNP・NT-proBNPの両値は臨床の場で心不全の重症度の評価、治療の指針、患者の転帰の予測に用いられています。これらの測定は心不全患者を効果的に管理するために極めて重要です。世界のBNP・NT-proBNP市場は、心血管疾患の有病率の上昇と心不全の早期診断・管理に対する意識の高まりにより、著しい成長を遂げています。診断技術の進歩と高齢者人口の増加が需要を押し上げています。さらに、新興市場における医療支出の増加と医療インフラの拡大が、市場の拡大をさらに後押ししています。

BNP・NT-proBNP市場は、心血管疾患の有病率の上昇と、早期診断と効果的な心不全管理の需要の増加によって推進されています。診断技術の進歩はこれらの検査の精度と効率を高め、臨床現場での採用拡大につながります。心臓疾患に罹患しやすい世界人口の高齢化が、市場の需要をさらに押し上げています。さらに、特に新興市場における医療支出の増加と医療インフラの拡充が市場成長に寄与しています。早期発見・早期介入の重要性に対する患者や医療提供者の意識の高まりも市場を支えています。継続的な研究開発努力の結果、革新的な製品や診断能力の向上がもたらされ、市場をさらに押し上げています。しかし、新興諸国では認知度が低く、高度な医療施設が限られていることが市場成長の妨げとなっています。償還の問題や厳しい規制要件も市場拡大の課題となっています。

世界のBNP・NT-proBNP市場の調査で考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、その他の地域です。2023年には、北米が収益面で市場を独占しました。北米のBNP・NT-proBNP市場は、高度な診断技術の普及を促進する高度な医療インフラによって特徴付けられます。この地域は心血管疾患の有病率が高く、効果的な管理のために早期かつ正確な診断が必要です。北米における多額の医療支出は、高度な診断検査や治療へのアクセスを保証しています。さらに、強力な研究開発活動が診断ツールの継続的な革新と改善に寄与しています。早期発見・早期介入の重要性に対する医療提供者や患者の認識が広まっていることも、市場の成長をさらに後押ししています。政府の支援政策と償還の枠組みも、この地域における市場の優位性に重要な役割を果たしています。アジア太平洋はBNP・NT-proBNPの世界市場で最も急成長しています。

目次

第1章 世界のBNP・NT-proBNP市場の定義と調査前提条件

  • 調査目的
  • 市場の定義
  • 調査前提条件
    • 包含と除外
    • 制限事項
    • 供給サイドの分析
      • 入手可能性
      • インフラ
      • 規制環境
      • 市場競争
      • 経済性（消費者の視点）
    • 需要サイド分析
      • 規制の枠組み
      • 技術の進歩
      • 環境への配慮
      • 消費者の意識と受容
  • 調査手法
  • 調査対象年
  • 通貨換算レート

第2章 エグゼクティブサマリー

  • BNP・NT-proBNPの世界市場規模・予測（2022年～2032年）
  • 地域別概要
  • セグメント別概要
    • 用途別
    • 検査場所別
  • 主要動向
  • 景気後退の影響
  • アナリストの結論・提言

第3章 世界のBNP・NT-proBNP市場力学

  • 市場促進要因
  • 市場の課題
  • 市場機会

第4章 世界のBNP・NT-proBNP市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
    • ポーターのファイブフォースモデルへの未来的アプローチ
    • ポーターのファイブフォースの影響分析
  • PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 BNP・NT-proBNPの世界市場規模・予測：用途別（2022年～2032年）

  • 心筋梗塞
  • うっ血性心不全
  • 急性冠症候群（ACS）
  • その他

第6章 BNP・NT-proBNPの世界市場規模・予測：検査場所別（2022年～2032年）

  • ポイントオブケア検査
  • ラボ検査

第7章 BNP・NT-proBNPの世界市場規模・予測：地域別（2022年～2032年）

  • 北米のBNP・NT-proBNP市場
    • 米国のBNP・NT-proBNP市場
      • 用途の内訳規模・予測（2022年～2032年）
      • 検査場所の内訳規模・予測（2022年～2032年）
    • カナダのBNP・NT-proBNP市場
  • 欧州のBNP・NT-proBNP市場
    • 英国のBNPとNTproBNP市場
    • ドイツのBNPとNTproBNP市場
    • フランスのBNP・NT-proBNP市場
    • スペインのBNP・NT-proBNP市場
    • イタリアのBNP・NT-proBNP市場
    • その他欧州のBNPとNTproBNP市場
  • アジア太平洋のBNP・NT-proBNP市場
    • 中国のBNPとNTproBNP市場
    • インドのBNPとNTproBNP市場
    • 日本のBNPとNTproBNP市場
    • オーストラリアのBNPとNTproBNP市場
    • 韓国のBNP・NT-proBNP市場
    • その他アジア太平洋のBNP・NT-proBNP市場
  • ラテンアメリカのBNP・NT-proBNP市場
    • ブラジルのBNP・NT-proBNP市場
    • メキシコのBNP・NT-proBNP市場
    • その他ラテンアメリカのBNPとNTproBNP市場
  • 中東・アフリカのBNP・NT-proBNP市場
    • サウジアラビアのBNPとNTproBNP市場
    • 南アフリカのBNP・NT-proBNP市場
    • その他中東・アフリカのBNP・NT-proBNP市場

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Siemens AG
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 市場戦略
    • Biomerieux SA
    • F Hoffman La Roche Ltd.
    • Danaher Corporation
    • Quidel Corporation
    • PerkinElmer Inc.
    • Gentian Diagnostics ASA
    • Scripps Laboratories
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
図表

LIST OF TABLES

  • TABLE 1. Global BNP And NTproBNP market, report scope
  • TABLE 2. Global BNP And NTproBNP market estimates & forecasts by Region 2022-2032 (USD Million)
  • TABLE 3. Global BNP And NTproBNP market estimates & forecasts by Application 2022-2032 (USD Million)
  • TABLE 4. Global BNP And NTproBNP market estimates & forecasts by Location of Testing 2022-2032 (USD Million)
  • TABLE 5. Global BNP And NTproBNP market by segment, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 6. Global BNP And NTproBNP market by region, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 7. Global BNP And NTproBNP market by segment, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 8. Global BNP And NTproBNP market by region, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 9. Global BNP And NTproBNP market by segment, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 10. Global BNP And NTproBNP market by region, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 11. Global BNP And NTproBNP market by segment, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 12. Global BNP And NTproBNP market by region, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 13. Global BNP And NTproBNP market by segment, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 14. Global BNP And NTproBNP market by region, estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 15. U.S. BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 16. U.S. BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 17. U.S. BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 18. Canada BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 19. Canada BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 20. Canada BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 21. UK BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 22. UK BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 23. UK BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 24. Germany BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 25. Germany BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 26. Germany BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 27. France BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 28. France BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 29. France BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 30. Italy BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 31. Italy BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 32. Italy BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 33. Spain BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 34. Spain BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 35. Spain BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 36. RoE BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 37. RoE BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 38. RoE BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 39. China BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 40. China BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 41. China BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 42. India BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 43. India BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 44. India BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 45. Japan BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 46. Japan BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 47. Japan BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 48. Australia BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 49. Australia BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 50. Australia BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 51. South Korea BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 52. South Korea BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 53. South Korea BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 54.
  • TABLE 55. RoAPAC BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 56. RoAPAC BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 57. RoAPAC BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 58. Brazil BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 59. Brazil BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 60. Brazil BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 61. Mexico BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 62. Mexico BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 63. Mexico BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 64. RoLA BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 65. RoLA BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 66. RoLA BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 67. Saudi Arabia BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 68. Saudi Arabia BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 69. Saudi Arabia BNP And NTproBNP market estimates & forecasts, 2022-2032 (USD Million)
  • TABLE 70. South Africa BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 71.
  • TABLE 72. South Africa BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 73. South Africa BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 74. RoMEA BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 75. RoMEA BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 76. RoMEA BNP And NTproBNP market estimates & forecasts by segment 2022-2032 (USD Million)
  • TABLE 77. List of secondary sources, used in the study of Global BNP And NTproBNP Market.
  • TABLE 78. List of primary sources, used in the study of Global BNP And NTproBNP Market.
  • TABLE 79. Years considered for the study.
  • TABLE 80. Exchange rates considered

LIST OF FIGURES

  • FIG 1. Global BNP And NTproBNP market, research methodology
  • FIG 2. Global BNP And NTproBNP market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods.
  • FIG 4. Global BNP And NTproBNP market, key trends 2023
  • FIG 5. Global BNP And NTproBNP market, growth prospects 2022-2032
  • FIG 6. Global BNP And NTproBNP market, porters 5 force model
  • FIG 7. Global BNP And NTproBNP market, pestel analysis
  • FIG 8. Global BNP And NTproBNP market, value chain analysis
  • FIG 9. Global BNP And NTproBNP market by segment, 2022 & 2032 (USD Million)
  • FIG 10. Global BNP And NTproBNP market by segment, 2022 & 2032 (USD Million)
  • FIG 11. Global BNP And NTproBNP market by segment, 2022 & 2032 (USD Million)
  • FIG 12. Global BNP And NTproBNP market by segment, 2022 & 2032 (USD Million)
  • FIG 13. Global BNP And NTproBNP market by segment, 2022 & 2032 (USD Million)
  • FIG 14. Global BNP And NTproBNP market, regional snapshot 2022 & 2032
  • FIG 15. North America BNP And NTproBNP market 2022 & 2032 (USD Million)
  • FIG 16. Europe BNP And NTproBNP market 2022 & 2032 (USD Million)
  • FIG 17. Asia pacific BNP And NTproBNP market 2022 & 2032 (USD Million)
  • FIG 18. Latin America BNP And NTproBNP market 2022 & 2032 (USD Million)
  • FIG 19. Middle East & Africa BNP And NTproBNP market 2022 & 2032 (USD Million)
  • FIG 20. Global BNP And NTproBNP market, company market share analysis (2023)
目次

Global BNP And NTproBNP Market is valued at approximately USD 1253.2 million in 2023 and is anticipated to grow with a healthy growth rate of more than 12.20% over the forecast period 2024-2032. BNP (B-type Natriuretic Peptide) and NT-proBNP (N-terminal prohormone of BNP) are biomarkers used to diagnose heart failure. BNP is a hormone produced by the heart's ventricles in response to increased pressure and volume overload. NT-proBNP (N-terminal pro b-type Natriuretic Peptide) is a precursor to BNP (B-type Natriuretic Peptide), both of which are released by the heart in response to ventricular volume expansion and pressure overload. NT-proBNP is cleaved from the same precursor molecule as BNP and is used as a biomarker for diagnosing and managing heart failure due to its stability and longer half-life in circulation. Both BNP and NT-proBNP levels are used in clinical settings to assess the severity of heart failure, guide treatment, and predict patient outcomes. Their measurement is crucial for managing heart failure patients effectively. The Global BNP and NT-proBNP Market is experiencing significant growth due to the rising prevalence of cardiovascular diseases and increasing awareness about early diagnosis and management of heart failure. Advances in diagnostic technologies and a growing elderly population are drifting demand. Additionally, increasing healthcare expenditures and expanding healthcare infrastructure in emerging markets are further propelling market expansion.

The BNP And NTproBNP market are propelled by the rising prevalence of cardiovascular diseases and the increasing demand for early diagnosis and effective heart failure management. Advances in diagnostic technology enhance the accuracy and efficiency of these tests, leading to greater adoption in clinical settings. The aging global population, which is more susceptible to heart conditions, further drives market demand. Additionally, rising healthcare expenditures and the expansion of healthcare infrastructure, particularly in emerging markets, contribute to market growth. Increased awareness among patients and healthcare providers about the importance of early detection and intervention also supports the market. Continuous research and development efforts result in innovative products and improved diagnostic capabilities, further boosting the market. However, lack of awareness and limited availability of advanced healthcare facilities in developing countries hinder market growth. Reimbursement issues and stringent regulatory requirements also pose challenges to market expansion.

The key regions considered for the Global BNP And NTproBNP Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America dominates the market in terms of revenue. The BNP And NTproBNP market in North America is characterized by its advanced healthcare infrastructure, which facilitates the widespread adoption of sophisticated diagnostic technologies. The region has a high prevalence of cardiovascular diseases, necessitating early and accurate diagnosis for effective management. Substantial healthcare spending in North America ensures access to advanced diagnostic tests and treatments. Additionally, strong research and development activities contribute to continuous innovation and improvement in diagnostic tools. Widespread awareness among healthcare providers and patients about the importance of early detection and intervention further drives market growth. Supportive government policies and reimbursement frameworks also play a crucial role in the market's dominance in this region. The Asia-Pacific region is the fastest-growing market for BNP And NTproBNP globally.

Major market player included in this report are:

  • Siemens AG
  • Biomerieux SA
  • F Hoffman La Roche Ltd.
  • Danaher Corporation
  • Quidel Corporation
  • PerkinElmer Inc.
  • Gentian Diagnostics ASA
  • Scripps Laboratories
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.

The detailed segments and sub-segment of the market are explained below:

By Application

  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome (ACS)
  • Others

By Location of Testing

  • Point of Care Testing
  • Laboratory Testing

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global BNP And NTproBNP Market Definition and Research Assumptions

  • 1.1. Research Objective
  • 1.2. Market Definition
  • 1.3. Research Assumptions
    • 1.3.1. Inclusion & Exclusion
    • 1.3.2. Limitations
    • 1.3.3. Supply Side Analysis
      • 1.3.3.1. Availability
      • 1.3.3.2. Infrastructure
      • 1.3.3.3. Regulatory Environment
      • 1.3.3.4. Market Competition
      • 1.3.3.5. Economic Viability (Consumer's Perspective)
    • 1.3.4. Demand Side Analysis
      • 1.3.4.1. Regulatory frameworks
      • 1.3.4.2. Technological Advancements
      • 1.3.4.3. Environmental Considerations
      • 1.3.4.4. Consumer Awareness & Acceptance
  • 1.4. Estimation Methodology
  • 1.5. Years Considered for the Study
  • 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

  • 2.1. Global BNP And NTproBNP Market Size & Forecast (2022- 2032)
  • 2.2. Regional Summary
  • 2.3. Segmental Summary
    • 2.3.1. By Application
    • 2.3.2. By Location of Testing
  • 2.4. Key Trends
  • 2.5. Recession Impact
  • 2.6. Analyst Recommendation & Conclusion

Chapter 3. Global BNP And NTproBNP Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Challenges
  • 3.3. Market Opportunities

Chapter 4. Global BNP And NTproBNP Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global BNP And NTproBNP Market Size & Forecasts by Application 2022-2032

  • 5.1. Myocardial Infarction
  • 5.2. Congestive Heart Failure
  • 5.3. Acute Coronary Syndrome (ACS)
  • 5.4. Others

Chapter 6. Global BNP And NTproBNP Market Size & Forecasts by Location of Testing 2022-2032

  • 6.1. Point of Care Testing
  • 6.2. Laboratory Testing

Chapter 7. Global BNP And NTproBNP Market Size & Forecasts by Region 2022-2032

  • 7.1. North America BNP And NTproBNP Market
    • 7.1.1. U.S. BNP And NTproBNP Market
      • 7.1.1.1. Application breakdown size & forecasts, 2022-2032
      • 7.1.1.2. Location of Testing breakdown size & forecasts, 2022-2032
    • 7.1.2. Canada BNP And NTproBNP Market
  • 7.2. Europe BNP And NTproBNP Market
    • 7.2.1. U.K. BNP And NTproBNP Market
    • 7.2.2. Germany BNP And NTproBNP Market
    • 7.2.3. France BNP And NTproBNP Market
    • 7.2.4. Spain BNP And NTproBNP Market
    • 7.2.5. Italy BNP And NTproBNP Market
    • 7.2.6. Rest of Europe BNP And NTproBNP Market
  • 7.3. Asia-Pacific BNP And NTproBNP Market
    • 7.3.1. China BNP And NTproBNP Market
    • 7.3.2. India BNP And NTproBNP Market
    • 7.3.3. Japan BNP And NTproBNP Market
    • 7.3.4. Australia BNP And NTproBNP Market
    • 7.3.5. South Korea BNP And NTproBNP Market
    • 7.3.6. Rest of Asia Pacific BNP And NTproBNP Market
  • 7.4. Latin America BNP And NTproBNP Market
    • 7.4.1. Brazil BNP And NTproBNP Market
    • 7.4.2. Mexico BNP And NTproBNP Market
    • 7.4.3. Rest of Latin America BNP And NTproBNP Market
  • 7.5. Middle East & Africa BNP And NTproBNP Market
    • 7.5.1. Saudi Arabia BNP And NTproBNP Market
    • 7.5.2. South Africa BNP And NTproBNP Market
    • 7.5.3. Rest of Middle East & Africa BNP And NTproBNP Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Siemens AG
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. Biomerieux SA
    • 8.3.3. F Hoffman La Roche Ltd.
    • 8.3.4. Danaher Corporation
    • 8.3.5. Quidel Corporation
    • 8.3.6. PerkinElmer Inc.
    • 8.3.7. Gentian Diagnostics ASA
    • 8.3.8. Scripps Laboratories
    • 8.3.9. Abbott Laboratories
    • 8.3.10. Bio-Rad Laboratories, Inc.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes